Ciphergen Issues Q4 Warning, Shares Plummet | GenomeWeb

NEW YORK, Jan 8 -   After protein chip maker Ciphergen announced its fourth quarter revenues would be 10 to 15 percent lower than it had originally expected, the company’s stock took a dive in Monday trading, closing 30 percent lower than its opening price.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.